查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
基因檢測市場：依應用、技術、產品和使用者進行預測和分析 - 附執行顧問指南（2024-2028）
市場調查報告書
商品編碼
1472612

基因檢測市場：依應用、技術、產品和使用者進行預測和分析 - 附執行顧問指南（2024-2028）

Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users. With Executive and Consultant Guides 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 559 Pages | 商品交期: 最快1-2個工作天內

價格

遺傳學在健康和疾病中的作用直到現在才被人們瞭解。 這些新知識加上較低的價格正在推動基因檢測產業創紀錄的成長。 新藥可能只對具有特定基因的人有效，這也推動了基因檢測產業的發展。 傳統基因檢測市場檢測量不斷增加，檢測範圍更加廣泛，為產業帶來新的活力和新的課題。

本報告審視了全球基因檢測市場，並提供了市場概述、應用、技術、產品和用戶的趨勢，以及進入市場的公司概況。

目錄

第一章市場指南

第 2 章介紹與市場定義

  • 本報告中基因檢測的定義
  • 基因體學革命
  • 市場定義
  • 調查方法
  • 觀點：醫療保健和 IVD 產業
  • 染色體、基因、表觀遺傳學

第三章市場概述

  • 市場准入組織
    • 學術研究所
    • 診斷測試開發人員
    • 儀器供應商
    • 藥品/試劑製造商
    • 病理供應商
    • 獨立的臨床實驗室
    • 公共國家/地區研究機構
    • 醫院實驗室
    • 臨床實驗室
    • 審計機構
    • 認證機構
  • 基因檢測 - 類型、範例和注意事項
  • 產業結構

第四章市場趨勢

  • 生長促進因素
  • 抑制生長的因素
  • 測量、自動化和診斷的趨勢

第 5 章基因檢測的最新趨勢

第六章主要公司簡介

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • Ancestry.com LLC
  • Anchor Dx
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • BioBam
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • BioGX
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Burning Rock
  • C2i Genomics
  • Cantata Bio
  • CareDx
  • Caris Molecular Diagnostics
  • Celemics
  • CellMax Life
  • Centogene
  • Cepheid（Danaher）
  • Circulogene
  • Clearbridge Biomedics
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics（MGI Tech）
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • DNAe
  • Easy DNA
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneDx Holdings
  • GeneFirst Ltd.
  • Genetic Technologies Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health（GPH）
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • Helix
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Norgen Biotek Corp.
  • Novogene
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Personalis
  • PGDx（Labcorp）
  • Precipio
  • PrecisionMed
  • Predictive Oncology
  • Promega
  • Qiagen
  • QuantuMDx
  • Revvity
  • Roche Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • VolitionRX
  • Zymo Research Corp

第七章世界市場規模

  • 依國家/地區劃分的世界市場
  • 依應用劃分的世界市場
  • 依科技劃分的世界市場
  • 依產品劃分的世界市場
  • 依使用者劃分的世界市場

第 8 章全球基因檢測市場（依應用）

  • 新生兒檢查
  • NIPT
  • 預測測試
  • 腫瘤檢查
  • DTC測試
  • 其他

第 9 章全球基因檢測市場（依技術）

  • PCR檢測
  • NGS
  • 細胞遺傳學檢測
  • 其他

第 10 章全球基因檢測市場（依產品）

  • 設備
  • 試劑/試劑盒
  • 軟體
  • 服務

第 11 章全球基因檢測市場（依使用者）

  • 學術
  • 臨床
  • 醫學
  • 工業及其他

第 12 章基因檢測的未來

第13章附錄

OVERVIEW:

Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Genetic Testing-Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. Genetic Testing Definition in This Report
  • 2.2. The Genomics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenue Market Size.
    • 2.3.2. Newborn Screening
    • 2.3.3. Non Invasise Pregnancy Testing
    • 2.3.4. Predictive
    • 2.3.5. Oncology
    • 2.3.6. Direct to Consumer
    • 2.3.7. Other Application
    • 2.3.8. PCR
    • 2.3.9. NGS
    • 2.3.10. Cytogenetic
    • 2.3.11. Other Technology
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare and the IVD Industry
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Diagnostics
    • 2.5.3. Important Role of Insurance for Diagnostics
  • 2.6. Chromosomes, Genes and Epigenetics
    • 2.6.1. Chromosomes
    • 2.6.2. Genes
    • 2.6.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Genetic Tests -Types, Examples and Discussion
    • 3.2.1. Preimplantation Genetic Diagnosis- An Emerging Market
    • 3.2.2. Prenatal Diagnosis-New Technologies Create Opportunity
    • 3.2.3. Newborn Screening
    • 3.2.4. Diagnostic Testing
    • 3.2.5. Carrier Testing
    • 3.2.6. Predictive and Presymptomatic Testing
    • 3.2.7. Pharmacogenomics
    • 3.2.8. Forensic Testing
    • 3.2.9. Parental Testing
    • 3.2.10. Ancestral Testing
  • 3.3. Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Genetic Discoveries Impact.
    • 4.1.2. The Aging Effect
    • 4.1.3. Pharmacogenomics
    • 4.1.4. Oncology and Liquid Biopsy Factors
    • 4.1.5. Fertility Practice
    • 4.1.6. Direct to Consumer
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Competition Effect
    • 4.2.2. The Cost Situation
    • 4.2.3. Testing usage analysis
    • 4.2.4. Wellness Effects
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Genetic Testing Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. Revvity Launches NGS Panel for Newborn Screening
  • 5.3. LetsGetChecked: MyGeneticScreen
  • 5.4. Sysmex, Hitachi to Develop Low-Cost Sequencers
  • 5.5. Fore Genomics Offering WGS Newborn Screening to Parents
  • 5.6. Clinical Validation of Long-Read WGS Assay
  • 5.7. Resolution Bio Acquisition-Exact Sciences Aims at Liquid Biopsy Market
  • 5.8. Novitas Rescinds Coverage for Multiple Genetic Tests
  • 5.9. PerkinElmer (now Revvity) Becomes Dx Life Science Firm
  • 5.10. New POC Genotyping Tests Based on Electromagnetic Detection
  • 5.11. GenoMe Dx Launching dPCR Cancer Test
  • 5.12. mDetect To Trial Breast Cancer Liquid Biopsy
  • 5.13. Genomics England, Aims to Sequence 100K Newborns
  • 5.14. Juno Diagnostics NIPT With At-Home Sample Collection
  • 5.15. Cardio Diagnostics Launches Genetic Cario Risk Test
  • 5.16. Universal Genetic Testing in Breast Cancer Further Supported
  • 5.17. Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
  • 5.18. MyOme Lands Investment for WGS
  • 5.19. Type 2 Diabetes GWAS Enables Risk Prediction
  • 5.20. LetsGetChecked to Acquire Veritas Genetics
  • 5.21. Guardant Health Plans New Comprehensive Assay
  • 5.22. Tesis Labs Raises $20M
  • 5.23. Sema4: Sema4 Elements
  • 5.24. Clarified Precision Medicine Acquires Interpares Biomedicine
  • 5.25. Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.26. Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • 5.27. NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • 5.28. Progenity Revenues Fall on COVID-19 Effect
  • 5.29. Natera Launches Tumor Genomic Profiling Assay
  • 5.30. 23andMe To Go Public
  • 5.31. Guardant Health to Offer Tumor Tissue Sequencing
  • 5.32. Ancestry Quits Health Offering
  • 5.33. DTC Firm MyDNA Merges With Gene by Gene

6. Profiles of Key Companies

  • 6.1. 10x Genomics, Inc.
  • 6.2. 23andME Inc.
  • 6.3. Abbott Laboratories
  • 6.4. Adaptive Biotechnologies
  • 6.5. Admera Health, LLC
  • 6.6. Agilent
  • 6.7. Akonni Biosystems
  • 6.8. Amoy Diagnostics Co., Ltd.
  • 6.9. Ancestry.com LLC
  • 6.10. Anchor Dx
  • 6.11. Arrayit Corporation
  • 6.12. ARUP Laboratories
  • 6.13. Aus Diagnostics
  • 6.14. BaseClear
  • 6.15. Baylor Miraca Genetics Laboratories
  • 6.16. Beckman Coulter Diagnostics (Danaher)
  • 6.17. Becton, Dickinson and Company
  • 6.18. BGI Genomics Co. Ltd
  • 6.19. Bioarray Genetics
  • 6.20. BioBam
  • 6.21. Biocept, Inc.
  • 6.22. Biodesix Inc.
  • 6.23. BioFluidica
  • 6.24. BioGenex
  • 6.25. BioGX
  • 6.26. Biolidics Ltd
  • 6.27. bioMerieux Diagnostics
  • 6.28. Bioneer Corporation
  • 6.29. Bio-Rad Laboratories, Inc
  • 6.30. Bio-Techne
  • 6.31. Burning Rock
  • 6.32. C2i Genomics
  • 6.33. Cantata Bio
  • 6.34. CareDx
  • 6.35. Caris Molecular Diagnostics
  • 6.36. Celemics
  • 6.37. CellMax Life
  • 6.38. Centogene
  • 6.39. Cepheid (Danaher)
  • 6.40. Circulogene
  • 6.41. Clearbridge Biomedics
  • 6.42. Clinical Genomics
  • 6.43. Color Genomics
  • 6.44. Complete Genomics (MGI Tech)
  • 6.45. CosmosID
  • 6.46. Dante Labs
  • 6.47. Datar Cancer Genetics Limited
  • 6.48. Diasorin S.p.A.
  • 6.49. DNAe
  • 6.50. Easy DNA
  • 6.51. Element Biosciences
  • 6.52. Epic Sciences
  • 6.53. Epigenomics AG
  • 6.54. Eurofins Scientific
  • 6.55. Excellerate Bioscience
  • 6.56. Fabric Genomics
  • 6.57. Freenome
  • 6.58. FUJIFILM Wako Diagnostics
  • 6.59. Fujirebio
  • 6.60. Fulgent Genetics
  • 6.61. Gene by Gene, Ltd.
  • 6.62. Genedrive
  • 6.63. GeneDx Holdings
  • 6.64. GeneFirst Ltd.
  • 6.65. Genetic Technologies Ltd.
  • 6.66. Genetron Holdings
  • 6.67. Genomics England
  • 6.68. Genomics Personalized Health (GPH)
  • 6.69. GenomOncology
  • 6.70. Genzyme Corporation
  • 6.71. Grifols
  • 6.72. Guardant Health
  • 6.73. Guardiome
  • 6.74. Helix
  • 6.75. Hologic
  • 6.76. HTG Molecular Diagnostics
  • 6.77. Human Longevity, Inc.
  • 6.78. iCellate
  • 6.79. Illumina
  • 6.80. Incell Dx
  • 6.81. Inivata
  • 6.82. Invitae Corporation
  • 6.83. Invivoscribe
  • 6.84. Karius
  • 6.85. Letsgetchecked
  • 6.86. Lunglife AI Inc
  • 6.87. Macrogen
  • 6.88. MDNA Life SCIENCES, Inc.
  • 6.89. MDx Health
  • 6.90. Medgenome
  • 6.91. Menarini Silicon Biosystems
  • 6.92. Meridian Bioscience
  • 6.93. Mesa Laboratories, Inc.
  • 6.94. Metabiomics Corp
  • 6.95. miR Scientific
  • 6.96. NantHealth, Inc.
  • 6.97. Natera
  • 6.98. Nebula Genomics
  • 6.99. NeoGenomics
  • 6.100. New England Biolabs, Inc.
  • 6.101. NGeneBio
  • 6.102. Norgen Biotek Corp.
  • 6.103. Novogene
  • 6.104. Omega Bioservices
  • 6.105. Oncocyte
  • 6.106. OncoDNA
  • 6.107. OpGen
  • 6.108. Origene Technologies
  • 6.109. Oxford Nanopore Technologies
  • 6.110. Pacific Biosciences
  • 6.111. Panagene
  • 6.112. PathoQuest S.A.
  • 6.113. Personalis
  • 6.114. PGDx (Labcorp)
  • 6.115. Precipio
  • 6.116. PrecisionMed
  • 6.117. Predictive Oncology
  • 6.118. Promega
  • 6.119. Qiagen
  • 6.120. QuantuMDx
  • 6.121. Revvity
  • 6.122. Roche Diagnostics
  • 6.123. Roswell Biotechnologies
  • 6.124. Seegene
  • 6.125. Sequencing.com
  • 6.126. Siemens Healthineers
  • 6.127. simfo GmbH
  • 6.128. Singlera Genomics Inc.
  • 6.129. Singular Genomics
  • 6.130. SkylineDx
  • 6.131. Standard BioTools
  • 6.132. Sysmex
  • 6.133. Sysmex Inostics
  • 6.134. Tempus Labs, Inc.
  • 6.135. Thermo Fisher Scientific
  • 6.136. Ultima Genomics
  • 6.137. Ultima Genomics
  • 6.138. Variantyx
  • 6.139. Vela Diagnostics
  • 6.140. VolitionRX
  • 6.141. Zymo Research Corp

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table-Global Market by Country
    • 7.1.2. Chart-Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table-Global Market by Application
    • 7.2.2. Chart-Application Share by Year
    • 7.2.3. Chart-Application Segment Growth Rates
    • 7.2.4. Chart-Application Segment Share Shifts
    • 7.2.5. Chart-Application Segment Share Base Year
    • 7.2.6. Chart-Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table-Global Market by Technology
    • 7.3.2. Chart-Technology Share by Year
    • 7.3.3. Chart-Technology Segment Growth Rates
    • 7.3.4. Chart-Technology Segment Share Shifts
    • 7.3.5. Chart-Technology Segment Share Base Year
    • 7.3.6. Chart-Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table-Global Market by Product
    • 7.4.2. Chart-Product Share by Year
    • 7.4.3. Chart-Product Segment Growth Rates
    • 7.4.4. Chart-Product Segment Share Shifts
    • 7.4.5. Chart-Product Segment Share Base Year
    • 7.4.6. Chart-Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table-Global Market by User
    • 7.5.2. Chart-User Share by Year
    • 7.5.3. Chart-User Segment Growth Rates
    • 7.5.4. Chart-User Segment Share Shifts
    • 7.5.5. Chart-User Segment Share Base Year
    • 7.5.6. Chart-User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Newborn Testing Market
    • 8.1.1. Table Newborn-by Country
    • 8.1.2. Chart-Newborn Growth
  • 8.2. NIPT Market
    • 8.2.1. Table NIPT-by Country
    • 8.2.2. Chart-NIPT Growth
  • 8.3. Predictive Testing Market
    • 8.3.1. Table Predictive-by Country
    • 8.3.2. Chart-Predictive Growth
  • 8.4. Oncology Testing Market
    • 8.4.1. Table Oncology-by Country
    • 8.4.2. Chart-Oncology Growth
  • 8.5. DTC Testing Market
    • 8.5.1. Table DTC-by Country
    • 8.5.2. Chart-DTC Growth
  • 8.6. Other Testing Market
    • 8.6.1. Table Other-by Country
    • 8.6.2. Chart-Other Growth

9. Global Genetic Testing Market by Technology

  • 9.1. PCR Testing Market
    • 9.1.1. Table PCR-by Country
    • 9.1.2. Chart-PCR Growth
  • 9.2. NGS Market
    • 9.2.1. Table NGS-by Country
    • 9.2.2. Chart-NGS Growth
  • 9.3. Cytogenetic Testing Market
    • 9.3.1. Table Cytogenetic-by Country
    • 9.3.2. Cytogenetic-Predictive Growth
  • 9.4. Other Testing Market
    • 9.4.1. Table Other-by Country
    • 9.4.2. Chart-Other Growth

10. Global Genetic Testing Market by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments-by Country
    • 10.1.2. Chart-Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits-by Country
    • 10.2.2. Chart-Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software-by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services-by Country
    • 10.4.2. Chart-Services Growth

11. Global Genetic Testing Market by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic-by Country
    • 11.1.2. Chart-Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical-by Country
    • 11.2.2. Chart-Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical-by Country
    • 11.3.2. Pharmaceutical-Predictive Growth
  • 11.4. Industrial and Other Market
    • 11.4.1. Table Industrial and Other-by Country
    • 11.4.2. Chart-Industrial and Other Growth

12. The Future of Genetic Testing

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule

Table of Tables

  • Table 1: Most Common Traditional Genetic Disorders
  • Table 2: The Base Pairs
  • Table 3: Market Players by Type
  • Table 4: The Different Types of Genetic Tests
  • Table 5: Five Factors Driving Growth
  • Table 6: Four Factors Limiting Growth
  • Table 7: Seven Key Diagnostic Laboratory Technology Trends
  • Table 8: Global Market by Country
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Product
  • Table 12: Global Market by User
  • Table 13: Newborn Segment by Country
  • Table 14: NIPT Segment by Country
  • Table 15: Predictive Segment by Country
  • Table 16: Oncology Segment by Country
  • Table 17: DTC Segment by Country
  • Table 18: Other Segment by Country
  • Table 19: PCR Segment by Country
  • Table 20: NGS Segment by Country
  • Table 21: Cytogenetic Segment by Country
  • Table 22: Other Segment by Country
  • Table 23: Instruments Segment by Country
  • Table 24: Reagents and Kits Segment by Country
  • Table 25: Software Segment by Country
  • Table 26: Services Segment by Country
  • Table 27: Academic Segment by Country
  • Table 28: Clinical Segment by Country
  • Table 29: Pharmaceutical Segment by Country
  • Table 30: Industrial and Other Segment by Country
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays
  • Table 33: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Health Care Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: DNA Strands and Chromosomes
  • Figure 4: Karyogram of Human Chromosomes
  • Figure 5: Size of Various Genomes
  • Figure 6: The Road to Diagnostics
  • Figure 7: The Changing Age of the World Population
  • Figure 8: Health Care Consumption by Age
  • Figure 9: Cancer Incidence-Age at Diagnosis
  • Figure 10: Centralized vs. Decentralized Laboratory Service
  • Figure 11: A Highly Multiplexed Syndromic Testing Unit
  • Figure 12: The Real Cost to Sequence the Human Genome
  • Figure 13: The Codevelopment Process
  • Figure 14: Comparing MDx Diagnostic and Traditional Testing
  • Figure 15: Country Market Shares
  • Figure 16: Application Share by Year
  • Figure 17: Application Segment Growth Rates
  • Figure 18: Segment Share Shifts
  • Figure 19: Application Segment Share Base Year
  • Figure 20: Application Segment Share Final Year
  • Figure 21: Technology Share by Year
  • Figure 22: Technology Segment Growth Rates
  • Figure 23: Technology Segment Share Shifts
  • Figure 24: Technology Segment Share Base Year
  • Figure 25: Technology Segment Share Final Year
  • Figure 26: Product Share by Year
  • Figure 27: Product Segment Growth Rates
  • Figure 28: Product Segment Share Shifts
  • Figure 29: Product Segment Share Base Year
  • Figure 30: Product Segment Share Final Year
  • Figure 31: User Share by Year
  • Figure 32: User Segment Growth Rates
  • Figure 33: User Segment Share Shifts
  • Figure 34: User Segment Share Base Year
  • Figure 35: User Segment Share Final Year
  • Figure 36: Newborn vs. Total Market Growth
  • Figure 37: NIPT vs. Total Market Growth
  • Figure 38: Predictive vs. Total Market Growth
  • Figure 39: Oncology vs. Total Market Growth
  • Figure 40: DTC vs. Total Market Growth
  • Figure 41: Other vs. Total Market Growth
  • Figure 42: PCR vs. Total Market Growth
  • Figure 43: NGS vs. Total Market Growth
  • Figure 44: Cytogenetic vs. Total Market Growth
  • Figure 45: Other vs. Total Market Growth
  • Figure 46: Instrument vs. Total Market Growth
  • Figure 47: Reagents and Kits vs. Total Market Growth
  • Figure 48: Software vs. Total Market Growth
  • Figure 49: Services vs. Total Market Growth
  • Figure 50: Academic vs. Total Market Growth
  • Figure 51: Clinical vs. Total Market Growth
  • Figure 52: Pharmaceutical vs. Total Market Growth
  • Figure 53: Industrial and Other vs. Total Market Growth
  • Figure 54: IVD Test Menu Growth
  • Figure 55: IVD Test Average Fees-A Ten Year View